Baxter International (BAX) Statistics

Baxter International Inc (BAX) is a global healthcare company that focuses on products for critical care, renal care, surgical care, and acute care. As of the recent statistics, the company has a market capitalization of $38.9 billion. BAX stock has a price-to-earnings ratio of 26.34 and a forward price-to-earnings ratio of 22.59. The stock's price-to-sales ratio is 3.67, and its price-to-book ratio is 6.23. These valuation metrics indicate that Baxter International Inc is moderately priced compared to its industry peers. The company's price-to-earnings growth ratio is 2.16, suggesting that its stock has growth potential.

In terms of fundamentals, Baxter International Inc has shown consistent growth over the years. The company's revenue has steadily increased from $10.56 billion in 2016 to $11.13 billion in 2019. The revenue per share for BAX stock is $26.44. Another important metric to consider is the enterprise value to earnings before interest, taxes, depreciation, and amortization (EBITDA) ratio, which is 16.92 for Baxter International Inc. This ratio indicates the company's ability to generate cash flow from its operations. Moreover, BAX has a healthy profit margin of 14.68%, indicating its ability to generate a significant return on sales.